Search research articles
Contact Us
Filters
Showing results (71-80 of 114) with videos related to
Page
of 12
Sort By:
Cancer Research
|
July 23, 2003
A new approach for the treatment of malignant melanoma: enhanced antitumor efficacy of an albumin-binding doxorubicin prodrug that is cleaved by matrix metalloproteinase 2
Ahmed M Mansour, Joachim Drevs, Norbert Esser, et al.
Epigenetics
|
June 28, 2013
Bi-PROF: bisulfite profiling of target regions using 454 GS FLX Titanium technology
Jasmin Gries, Dirk Schumacher, Julia Arand, et al.
Cancer Medicine
|
October 14, 2016
Pharmacologic activity and pharmacokinetics of metabolites of regorafenib in preclinical models
Dieter Zopf, Iduna Fichtner, Ajay Bhargava, et al.
International Journal of Cancer
|
June 1, 2017
Basal subtype is predictive for response to cetuximab treatment in patient-derived xenografts of squamous cell head and neck cancer
Konrad Klinghammer, Raik Otto, Jan-Dirk Raguse, et al.
Investigational New Drugs
|
June 10, 2011
Screening of well-established drugs targeting cancer metabolism: reproducibility of the efficacy of a highly effective drug combination in mice
Mohammad Abolhassani, Adeline Guais, Edward Sanders, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
December 11, 2007
In vivo and in vitro activity and mechanism of action of the multidrug cytarabine-L-glycerylyl-fluorodeoxyuridine
Irene V Bijnsdorp, Reto A Schwendener, Herbert Schott, et al.
Human Gene Therapy. Clinical Development
|
September 27, 2013
A seven-year storage report of good manufacturing practice-grade naked plasmid DNA: stability, topology, and in vitro/in vivo functional analysis
Wolfgang Walther, Marco Schmeer, Dennis Kobelt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 30, 2013
Synergistic activity of bortezomib and HDACi in preclinical models of B-cell precursor acute lymphoblastic leukemia via modulation of p53, PI3K/AKT, and NF-κB
Lorenz Bastian, Jana Hof, Madlen Pfau, et al.
Molecular Oncology
|
February 8, 2014
Preclinical study on combined chemo- and nonviral gene therapy for sensitization of melanoma using a human TNF-alpha expressing MIDGE DNA vector
Dennis Kobelt, Jutta Aumann, Manuel Schmidt, et al.
Neoplasia (New York, N.Y.)
|
March 16, 2011
Intervening in β-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis
Ulrike Stein, Franziska Arlt, Janice Smith, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 114) with videos related to
Sort By:
Page
of 12
Cancer Research
|
July 23, 2003
A new approach for the treatment of malignant melanoma: enhanced antitumor efficacy of an albumin-binding doxorubicin prodrug that is cleaved by matrix metalloproteinase 2
Ahmed M Mansour, Joachim Drevs, Norbert Esser, et al.
Epigenetics
|
June 28, 2013
Bi-PROF: bisulfite profiling of target regions using 454 GS FLX Titanium technology
Jasmin Gries, Dirk Schumacher, Julia Arand, et al.
Cancer Medicine
|
October 14, 2016
Pharmacologic activity and pharmacokinetics of metabolites of regorafenib in preclinical models
Dieter Zopf, Iduna Fichtner, Ajay Bhargava, et al.
International Journal of Cancer
|
June 1, 2017
Basal subtype is predictive for response to cetuximab treatment in patient-derived xenografts of squamous cell head and neck cancer
Konrad Klinghammer, Raik Otto, Jan-Dirk Raguse, et al.
Investigational New Drugs
|
June 10, 2011
Screening of well-established drugs targeting cancer metabolism: reproducibility of the efficacy of a highly effective drug combination in mice
Mohammad Abolhassani, Adeline Guais, Edward Sanders, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
December 11, 2007
In vivo and in vitro activity and mechanism of action of the multidrug cytarabine-L-glycerylyl-fluorodeoxyuridine
Irene V Bijnsdorp, Reto A Schwendener, Herbert Schott, et al.
Human Gene Therapy. Clinical Development
|
September 27, 2013
A seven-year storage report of good manufacturing practice-grade naked plasmid DNA: stability, topology, and in vitro/in vivo functional analysis
Wolfgang Walther, Marco Schmeer, Dennis Kobelt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 30, 2013
Synergistic activity of bortezomib and HDACi in preclinical models of B-cell precursor acute lymphoblastic leukemia via modulation of p53, PI3K/AKT, and NF-κB
Lorenz Bastian, Jana Hof, Madlen Pfau, et al.
Molecular Oncology
|
February 8, 2014
Preclinical study on combined chemo- and nonviral gene therapy for sensitization of melanoma using a human TNF-alpha expressing MIDGE DNA vector
Dennis Kobelt, Jutta Aumann, Manuel Schmidt, et al.
Neoplasia (New York, N.Y.)
|
March 16, 2011
Intervening in β-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis
Ulrike Stein, Franziska Arlt, Janice Smith, et al.
Page
of 12